Globus Medical Reaffirms 2024 Guidance: Sees Adj. EPS $2.68-$2.70, Revenue $2.45B-$2.475B
Portfolio Pulse from Benzinga Newsdesk
Globus Medical has reaffirmed its 2024 financial guidance, projecting an adjusted EPS of $2.68-$2.70 and revenue in the range of $2.45B-$2.475B.

February 20, 2024 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Globus Medical reaffirms its 2024 financial guidance with an adjusted EPS of $2.68-$2.70 and revenue projections of $2.45B-$2.475B.
Reaffirming financial guidance, especially with specific targets for both EPS and revenue, tends to instill confidence in investors about the company's future performance and stability. This clarity and positive outlook are likely to have a favorable impact on the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100